Breaking News Instant updates and real-time market news.

CLSD

Clearside Biomedical

$2.21

-0.11 (-4.74%)

16:18
01/10/20
01/10
16:18
01/10/20
16:18

Clearside Biomedical files to sell 3.18M shares of common stock for holders

CLSD Clearside Biomedical
$2.21

-0.11 (-4.74%)

08/13/19
LDLW
08/13/19
DOWNGRADE
Target $2
LDLW
Hold
Laidlaw downgrades Clearside Biomedical to Hold after Xipere partnering
As previously reported, Laidlaw analyst Francois Brisebois downgraded Clearside Biomedical to Hold from Buy as he believes the company's decision to out-license their main product, Xipere, adds uncertainty for the foreseeable future in terms of topline growth. He lowered his price target on Clearside shares to $2 from $5, stating that he values CLS-TA for U.S. uveitis at $1.50 per share and the company's cash and technology at 50c per share.
08/22/19
JMPS
08/22/19
NO CHANGE
JMPS
Clearside Biomedical price target lowered to $3 from $4 at JMP Securities
JMP Securities analyst Donald Ellis reiterated an Outperform rating on Clearside Biomedical, but it lowering his price target on shares to $3 from $4 after the FDA requested additional stability data for Xipere, which will delay a final FDA approval and require an NDA re-submission in Q1 of 2020. Ellis added that he now sees Xipere approval in Q3 of 2020.
10/14/19
ROTH
10/14/19
NO CHANGE
ROTH
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
Commenting on the Ophthalmology space, Roth Capital analyst Zegbeh Jallah highlights her conviction for stronger valuations, driven by the increasing number of companies with innovative pipelines, and pending changes at both the FDA and CMS. The analyst suspects that these changes could lead to more wins in the space, which could drive valuations. Further, she cautions investors to keep "their eyes peeled on developments in the space." Jallah sees this as possible relevant for KalVista (KALV), Regenxbio (RGNX), Kala Pharmaceuticals (KALA), Kodiak Sciences (KOD), Regeneron (REGN), Aerie Pharmaceuticals (AERI), Applied Genetic (AGTC), Aldeyra (ALDX), Adverum Biotechnologies (ADVM), Clearside Biomedical (CLSD), Ocugen (OCGN), and many others.
12/17/19
JMPS
12/17/19
NO CHANGE
Target $4
JMPS
Outperform
FDA to accept RVO clinial use data from Clearside, says JMP Securities
JMP Securities analyst Donald Ellis reiterated an Outperform rating and $4 price target on Clearside Biomedical after the FDA agreed to accept clinical use data from the macular edema associated with the RVO study, removing the need for an additional clinical use study for the uveitis NDA. The analyst tells investors in a research note that Clearside plans to resubmit the NDA for XIPERE in non-infectious uveitis in 2Q20 and expects an FDA review within six months of submission. He expects Clearside's cash to last until at least the third quarter, but adds that removing the need for the clinical use study likely extends the cash runway.

TODAY'S FREE FLY STORIES

PG

Procter & Gamble

$126.65

0.54 (0.43%)

, UNP

Union Pacific

$181.23

-1.27 (-0.70%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$126.65

0.54 (0.43%)

UNP

Union Pacific

$181.23

-1.27 (-0.70%)

KMB

Kimberly-Clark

$145.50

0.91 (0.63%)

VFC

VF Corp.

$95.12

0.49 (0.52%)

LUV

Southwest

$53.64

0.1 (0.19%)

MTB

M&T Bank

$162.54

1.655 (1.03%)

KEY

KeyCorp

$19.61

0.11 (0.56%)

HBAN

Huntington Bancshares

$14.84

0.22 (1.51%)

AAL

American Airlines

$27.50

0.29 (1.07%)

JBLU

JetBlue

$19.90

0.81 (4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 17

    Feb

  • 04

    Mar

TXN

Texas Instruments

$133.66

2.81 (2.15%)

, KMI

Kinder Morgan

$21.05

0.12 (0.57%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$133.66

2.81 (2.15%)

KMI

Kinder Morgan

$21.05

0.12 (0.57%)

CTXS

Citrix

$119.46

1.67 (1.42%)

TER

Teradyne

$73.17

1.64 (2.29%)

PTC

PTC

$79.86

0.93 (1.18%)

STLD

Steel Dynamics

$32.05

0.14 (0.44%)

SLM

Sallie Mae

$9.15

0.31 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

XOM

Exxon Mobil

$67.01

-0.58 (-0.86%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Periodicals
Exxon Mobil set to kick off U.K., Germany asset sales, Bloomberg says »

Exxon Mobil intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

CHEOY

Cochlear

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/22/20
01/22
14:16
01/22/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPG

Simon Property

$146.15

-2.96 (-1.99%)

14:15
01/22/20
01/22
14:15
01/22/20
14:15
Options
Simon Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

, PKX

Posco

$51.39

-0.15 (-0.29%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
On The Fly
FuelCell plunges on bigger than expected loss, revenue miss »

Shares of FuelCell (FCEL)…

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

PKX

Posco

$51.39

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

NK

NantKwest

$5.94

-0.32 (-5.11%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
Hot Stocks
Breaking Hot Stocks news story on NantKwest 

NantKwest trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$5.90

-0.36 (-5.75%)

14:09
01/22/20
01/22
14:09
01/22/20
14:09
Hot Stocks
Breaking Hot Stocks news story on NantKwest »

NantKwest trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRP

Neurotrope

$2.73

1.3 (90.91%)

14:08
01/22/20
01/22
14:08
01/22/20
14:08
Syndicate
Neurotrope announces $18M registered direct offering »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$222.17

0.69 (0.31%)

, TWTR

Twitter

$34.34

0.25 (0.73%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
On The Fly
#SocialStocks: No ads in WhatsApp, No edit button for Twitter »

Welcome to…

FB

Facebook

$222.17

0.69 (0.31%)

TWTR

Twitter

$34.34

0.25 (0.73%)

SNAP

Snap

$19.25

0.24 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 29

    Jan

  • 04

    Feb

  • 06

    Feb

MPLX

MPLX

$25.13

-0.54 (-2.10%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
Options
MPLX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$310.94

-2.37 (-0.76%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Periodicals
Boeing CEO says 737 MAX return delayed due to simulator training, CNBC reports »

Boeing CEO Dave Calhoun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

CNCE

Concert Pharmaceuticals

$10.86

1.04 (10.59%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$311.75

-1.56 (-0.50%)

13:58
01/22/20
01/22
13:58
01/22/20
13:58
Periodicals
Boeing aims to resume 737 MAX production before return to service, CNBC says »

Dave Calhoun, the new CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TEVA

Teva

$10.53

0.505 (5.04%)

13:55
01/22/20
01/22
13:55
01/22/20
13:55
Conference/Events
The Food and Drug Law Institute holds a webinar »

The FDLI summarizes the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 10

    Feb

  • 12

    Feb

  • 09

    Mar

CNCE

Concert Pharmaceuticals

$10.37

0.55 (5.60%)

13:53
01/22/20
01/22
13:53
01/22/20
13:53
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAF

GrafTech

$13.00

0.61 (4.92%)

13:45
01/22/20
01/22
13:45
01/22/20
13:45
Options
GrafTech call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

MSFT

Microsoft

$166.62

0.14 (0.08%)

13:38
01/22/20
01/22
13:38
01/22/20
13:38
Hot Stocks
Microsoft: Misconfiguration investigation found no malicious use of database »

Microsoft said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 25

    Feb

13:35
01/22/20
01/22
13:35
01/22/20
13:35
General news
Treasury Action: there's been no real inspiration in the markets today »

Treasury Action:…

MDP

Meredith

$30.49

-0.1 (-0.33%)

13:34
01/22/20
01/22
13:34
01/22/20
13:34
Hot Stocks
Meredith to partner with Ayesha Curry to launch new quarterly brand »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

BA

Boeing

$304.40

-8.91 (-2.84%)

13:31
01/22/20
01/22
13:31
01/22/20
13:31
Periodicals
Boeing CEO says 737 MAX output may restart in 'a few months,' Bloomberg reports »

Bloomberg cites comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VFF

Village Farms

$5.84

0.01 (0.17%)

13:30
01/22/20
01/22
13:30
01/22/20
13:30
Options
Buyer crosses wide spread for Village Farm upside calls »

Buyer crosses wide spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$33.66

-0.02 (-0.06%)

13:27
01/22/20
01/22
13:27
01/22/20
13:27
Periodicals
New York Times seen as potential suitor for 'Serial' podcast maker, WSJ says »

Serial Productions, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.